At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 34 enrolled
Drug / intervention
tamsulosin capsules +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Single Center, Single Dose, Open-label, Randomized, Two-way Crossover Study to Determine Bioequivalence of Two Formulations Containing Tamsulosin HCl 04.mg MR Capsules in at Least 30 Healthy Male Subjects Under Fasted Conditions
In Brief
A Phase 1 clinical trial evaluating tamsulosin capsules and tamsulosin HCl for Prostatic Hyperplasia. Completed, enrolled 34 participants.
Detailed Summary
A bio-equivalence of 2 different capsule formulations in fasted subjects
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstatic Hyperplasia
Countries--
Collaborators--
Timeline
Phase 1CompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 2015
Enrollment StartApr 2015
Primary CompletionMay 2015
TodayJul 2026
First PostedApr 16, 2015
Enrollment StartApr 30, 2015
Primary CompletionMay 31, 2015
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 11.2 years ago
Interventions
tamsulosin capsulesdrug
tamsulosin HCldrug